Clinical cardiovascular risk interpretable prediction method based on causal inference
By constructing a structural causal model and combining it with cross-center transfer learning, the problem of insufficient causal reasoning in existing cardiovascular risk prediction methods is solved. Mechanism-level path decomposition and individualized interpretable prediction are achieved, improving the robustness and cross-center consistency of the model.
Patent Information
- Application Number
- CN202610731954.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-05-26
- Publication Date
- 2026-07-24
AI Technical Summary
Existing clinical cardiovascular risk prediction methods lack causal reasoning mechanisms and cannot reveal the path mechanisms and mediating relationships of disease occurrence. This results in poor model transferability, insufficient generalization ability, and insufficient interpretability, making it difficult to form cross-center consistent causal estimates and population-individual level prediction loops.
By integrating causal inference and cross-center transfer learning, a structural causal model is constructed to establish an identifiable formula for intervention-type mediation effects. Combining dual robust estimation and target maximum likelihood, robust and interpretable output middleware is generated, and cross-center consistent estimation is achieved through cross-domain transferable do-calculus.
It achieves mechanism-level pathway decomposition and individualized interpretable prediction of cardiovascular risk, and has strong robustness, high transferability and excellent clinical interpretability. It can obtain reliable prediction results even in the presence of exposure-induced confounding and time-varying covariates.
